{
    "title": "Regeneron pauses patient enrollment in lymphoma drug trials",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9053433/Regeneron-pauses-patient-enrollment-lymphoma-drug-trials.html",
    "date": "2020-12-14",
    "keywords": [
        "enrollment",
        "drug",
        "trial",
        "cancer",
        "odronextamab",
        "treatment",
        "company",
        "release",
        "syndrome",
        "bnhl",
        "dec",
        "monday",
        "health",
        "regulator",
        "drugmaker",
        "httpsinvestorregeneroncomstaticfiles690eeaf2643e44eb9c3fbaad97eb9703",
        "consent",
        "food",
        "administration",
        "hold",
        "occurrence",
        "response",
        "cytokine",
        "fever",
        "headache",
        "decision",
        "earlystage",
        "bcell",
        "lymphomas",
        "leukemia",
        "midstage",
        "regeneron",
        "fda",
        "goal",
        "quarter",
        "reporting",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}